Eiken Chemical Co., Ltd. (TYO:4549)
2,322.00
+10.00 (0.43%)
Oct 20, 2025, 2:41 PM JST
Eiken Chemical Revenue
Eiken Chemical had revenue of 10.2 billion JPY in the quarter ending June 30, 2025, with 7.12% growth. This brings the company's revenue in the last twelve months to 41.22 billion, up 3.80% year-over-year. In the fiscal year ending March 31, 2025, Eiken Chemical had annual revenue of 40.54 billion with 1.22% growth.
Revenue (ttm)
41.22B
Revenue Growth
+3.80%
P/S Ratio
1.84
Revenue / Employee
58.71M
Employees
702
Market Cap
75.72B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 40.54B | 487.00M | 1.22% |
Mar 31, 2024 | 40.05B | -3.22B | -7.44% |
Mar 31, 2023 | 43.27B | 275.00M | 0.64% |
Mar 31, 2022 | 43.00B | 4.33B | 11.20% |
Mar 31, 2021 | 38.67B | 2.08B | 5.69% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Takeda Pharmaceutical Company | 4,480.25B |
Otsuka Holdings | 2,401.70B |
Astellas Pharma | 1,944.99B |
Daiichi Sankyo Company | 1,924.68B |
Chugai Pharmaceutical | 1,196.21B |
Terumo | 1,037.94B |
Olympus | 969.02B |
HOYA Corporation | 876.09B |